NIH Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed), PAR-22-090. CFDA #s 93.393, 93.394, 93.396, 93.399, 93.395, 93.121, 93.846. The combined budget for direct costs for the two-year project may not exceed $275,000. No more than $200,000 may be requested in any single year. Applications Due: 10/16/2024.
The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to demonstrate feasibility and potential utility of new capabilities or improvements in quality, speed, efficacy, operability, costs, and/or accessibility of solutions to problems in basic biomedical, pre-clinical, or clinical research, clinical care delivery, or accessibility.
Interested? Track this NIH Bioengineering Opportunity in Pivot-RP
|